Literature DB >> 10634342

Resistance, fitness, adherence, and potency: mapping the paths to virologic failure.

M Markowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10634342     DOI： 10.1001/jama.283.2.250

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  HIV therapy: managing resistance.

Authors:  D Wodarz; M A Nowak
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Evolution of drug-resistant viral populations during interruption of antiretroviral therapy.

Authors:  Dongning Wang; Charles B Hicks; Neela D Goswami; Emi Tafoya; Ruy M Ribeiro; Fangping Cai; Alan S Perelson; Feng Gao
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.

Authors:  David A Price; George Scullard; Annette Oxenius; Ruth Braganza; Simon A Beddows; Shamim Kazmi; John R Clarke; Gabriele E Johnson; Jonathan N Weber; Rodney E Phillips
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

4.  Drug resistance mutations in protease gene of HIV-1 subtype C infected patient population.

Authors:  Mohammad Misbah; Poonam Gupta; Gaurav Roy; Suresh Kumar; Mohammad Husain
Journal:  Virusdisease       Date:  2021-07-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.